CN106420905A - Capsule for increasing bone density and preparation method of capsules - Google Patents
Capsule for increasing bone density and preparation method of capsules Download PDFInfo
- Publication number
- CN106420905A CN106420905A CN201611079024.6A CN201611079024A CN106420905A CN 106420905 A CN106420905 A CN 106420905A CN 201611079024 A CN201611079024 A CN 201611079024A CN 106420905 A CN106420905 A CN 106420905A
- Authority
- CN
- China
- Prior art keywords
- capsule
- parts
- bone density
- extract
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a capsule for increasing bone density and a preparation method of the capsules. The capsule comprises a capsule body and filler filling the capsule body, wherein the filler is prepared from the following raw materials in parts by weight: 25 parts of extracts of fortune's drynaria rhizome, 25 parts of eucommia bark extracts, 80 parts of milkvetch root extracts, 70 parts of Kudzuvine root extracts, 180 parts of oyster extracts, 18 parts of starch and 2 parts of magnesium stearate. The capsule strengthens the activity of osteoblasts, promotes production and secretion of bone matrixes and bone mineralization and improves the body immune function; the components are applied compatibly, realize a synergistic effect, improve calcium absorption of human bodies together and increase the bone density; the preparation method is reasonable in process and high in operability and easily realizes large-scale production.
Description
Technical field
The present invention relates to a kind of medicinal preparation being characterized with soft capsule preparation, more particularly, to a kind of increase bone density
Capsule and preparation method thereof.
Background technology
Osteoporosises are osteoporosis, are one group of osteopathia that many reasons cause, and osseous tissue has normal calcification, calcium salt
It is in normal rates with substrate, become with the metabolic osteopathy that unit volume inner bone tissues amount is reduced to feature.In most osteoporosises
In, caused by the minimizing of osseous tissue increases mainly due to bone absorption.With skeleton pain, it is easy to fracture and is characterized.Clinical manifestation is
Pain, height shorten, bow-backed, fracture, respiratory function decline etc., are that a kind of bone amount of general reduces and osseous tissue microstructure
Change, the fragility of bone increases, the intensity decreases of bone, in the case of hurtless measure or mild trauma, the disease fractured can occur
Disease.Diagnosis of osteoporosis is mainly measured and quantitative analyses to the mineral in skeleton in vitro by instrument, that is, measure
Bone density is determining whether there is osteoporosises and the order of severity.At present, people mainly take enhancing to take exercise, reinforcement dietetic nutrition enters
The methods such as row tonic strengthen calcareous supplement, but due to body due to, equal difficult to reach therapeutic effect.
Therefore, produce one kind effectively to delay and resist bone loss, increase bone density, have no side effect safely, preparation method letter
Single capsule of increase bone density and preparation method thereof, has extensive market prospect.
Content of the invention
For the deficiencies in the prior art, the present invention provides one kind effectively to delay and resist bone loss, increase bone density, safety
Have no side effect, preparation method simply increases capsule of bone density and preparation method thereof, be used for overcoming of the prior art many
Defect.
The technology contents of the present invention are realized in:A kind of increase bone density capsule, include capsule body be filled in
Implant in capsule body is made, and described implant is to be prepared from by the raw material of following parts by weight:Rhizoma Drynariae carries
Take 25 parts of thing, 25 parts of Cortex Eucommiae extract, 80 parts of Radix Astragali extract, 70 parts of Radix Puerariae extract, 180 parts of Concha Ostreae extract, starch 18
Part, 2 parts of magnesium stearate.
Described capsule body is No. 0 Capsuleses.
A kind of preparation method of the capsule increasing bone density as above, its preparation method is as follows:
1)The raw material of above-mentioned parts by weight is crossed respectively standby after 60 mesh sieves;
2)The raw material of the above-mentioned parts by weight after sieving is placed in mixer and mixes 30 minutes, obtains mixed powder;
3)Using capsule filling machine, above-mentioned mixed powder is filled in capsule body, the capsule body filled is placed in capsule polisher
Middle polishing, is screened after polishing, chooses flat capsule, broken capsule, empty pocket and leakage powder capsule;
4)Pass through Aluminium-coating Packer with the PVC board meeting YBB00212005 standard and the aluminium foil meeting YBB00152002 standard
To step 3)Capsule after middle screening is wrapped inside dress, the every plate of packing specification 12;
5)Outer package operation mounted box, every box 2 plate will be proceeded to through the packaged capsule of Aluminium-coating Packer, obtain finished product, finished product will be used
Co60Sterilizing, dosage is 6KGy, extracts inspection, put in storage after the assay was approved after sterilizing.
The present invention has following good effect:The Therapeutic Principle of integrated control osteoporosis of the present invention, according to rigorous
Science carry out compatibility, select Rhizoma Drynariae extract, Cortex Eucommiae extract, Radix Astragali extract, Radix Puerariae extract and Concha Ostreae extract
For major ingredient, adding starch and magnesium stearate is adjuvant, strengthens osteoblastic activity, promotes generation, secretion and the bone of bone matrix
Mineralising, improves body's immunity, each component compatibility application, produces synergism, and the common raising absorption to calcium for the human body increases
Bone density.Using capsule preparations, have carry, taking convenience and easily absorb the features such as.Another research through pharmacological toxicology shows, this
Bright compositionss safe without toxic side effect, the effect of be improved bone density.The present invention is with strong points, effect is obvious, is a kind of safety
Reliability, the health food of the increase bone density of salubrity body, defying age.The preparation method rational technology of the present invention, workable,
Easily accomplish scale production.
Rhizoma Drynariae, nature and flavor are bitter, temperature.Another name:Precipice Rhizoma Zingiberis Recens, rock connect Rhizoma Zingiberis Recens, delevay drynaria, the broken benefit of meat, the broken benefit of stone, flying apsaras Mus, Niu Feilong,
Sudden wind, moth grass.Polypodiales, Davalliaceae pteridophyta, whole year all can excavate, and removes silt, be dried, or burn remove floss again
(Scale).This product is in flat strip, bends more, has branch, the close ramentum by dark-brown to burgundy in surface, and softness is such as
Hair, is in sepia or crineous through the fire person of burning, and both sides and upper surface all have raised or recessed circular leaf scar, and minority has petiole residual
Base and fibrous root residual.Body is light, and matter is crisp, frangibility, section rufous, and vascular bundle is in yellow point-like, arranges cyclization.Odorless, lightly seasoned,
Micro-puckery.The strong bone of kidney tonifying, continues and hinders pain relieving.For lumbago due to renal deficiency, Hiccough and deaf, odontoseisiies, falling winks frustrates, injured bone;External treatment
Alopecia areata, vitiligo.Pharmacological action:1st, according to the researchs such as China Medicine University's week copper water, Rhizoma Drynariae extract (suitable active compound 20g/kg
) gavage to experimental rat bone injury healing have facilitation.2. Rhizoma Drynariae water decoction 7.5-50g/kg gavage, to rat experiment
Property arthritis have stimulation bone articular cartilage compensatory cellular proliferative effect, and can partly improve due to mechanical stress line change make
Become the degeneration of articular cartilage, thus reducing osteoarthritis variability.3. to increase In vitro culture big for Rhizoma Drynariae flavanone glycoside
The Beating Rate of white mouse neonatal rat myocardial cell, makes contraction strong, and myocardial cell is had pace-making act on, and its mechanism of action may
It is similar to a kind of beta-receptor agonist.4. Rhizoma Drynariae decocting liquid (100%) 0.8ml/kg is administered orally, can be obvious to Experimental Hyperlipemia rabbit
Prophylactic serum cholesterol, the rising of triglyceride, and the formation of aorta wall atherosclerotic plaque can be prevented.5. guinea-pig studies carry
Show, Rhizoma Drynariae decoct and kanamycin share the toxic action that can mitigate kanamycin to cochlea, but in can not controlling after drug withdrawal
The deaf development of toxicity.6. Rhizoma Drynariae decoct in vitro can suppress staphylococcic growth.Rhizoma Drynariae water decoction 7.5,10,
25th, 50g/kg is administered orally, and to chondrocytes of rat osteoarthritis mode, has the chondrocyte that has some improvement, postpones cell regeneration change, fall
The function of low osteoarthritis variability, increases with dosage, and effect increases, and acts on preferably after being administered two months.Rhizoma Drynariae decocting
Agent 100g (crude drug)/kg/ days is administered orally giving kanamycin for first 2 hours, continuous 8 days, can mitigate the poison to cochlea for the kanamycin
Property, but the development of toxic deafness after drug withdrawal can not be controlled.
The Cortex Eucommiae is Eucommiaceae Cortex Eucommiae platymiscium, containing higher chlorogenic acid.Chlorogenic acid also known as caffeoyl guinic acid, are plants
A kind of Phenylpropanoid Glycosides class material of the intermediate product synthesis through phosphopentose pathway (HMS) during aerobic respiration.In recent years
Result of study shows, Chlorogenic Acid in Eucommia ulmoides Oliv. Leaves content is higher, up to 1 to 5.5.Chlorogenic acid has function of gallbladder promoting, antibacterial, antiviral, fall
Pressure, the multiple pharmacological effect such as leukocyte increasing and stimulating central nervous system system, is the industry such as health product, food, medicine, cosmetics
Important source material, hence with Folium Eucommiae produce chlorogenic acid there are huge social benefit and economic implications.Pharmacological action nature and flavor
Return through:Temperature;Sweet;Return liver and kidney channel.Indication:Invigorating the liver and kidney, bone and muscle strengthening, antiabortive.For lumbago due to renal deficiency, muscles and bones is powerless, gestation leakage
Blood, frequent fetal movement;Hypertension.Test proves, Folium Eucommiae extract has broad-spectrum antibacterial, antioxidation, removes free radical and raising
Immunity etc. acts on, and has promotion poultry fast-growth;Prevent and cure diseases;The effectiveness such as substitute antibiotics.
Radix Astragali extract has enhancing immunity, strengthens energy, resisting fatigue, mutation, liver protection, the work of suppression osteoclast
With.Astragalus polysaccharidess have blood fat reducing, that is, reduce the effect of cholesterol and triglyceride, high density lipoprotein increasing;Can prevent
With treatment cardiovascular and cerebrovascular disease, such as atherosclerosiss, coronary artery pathological changes, peripheral angiopathy and hyperlipemia etc..Yellow
Stilbene first glycosides has the effect significantly reducing blood glucose, glycolated hemoglobin and urine protein, it is possible to decrease the AGEs in renal cortex and serum,
Display astragaloside has antioxidation, and has inhibitory action to aldose reductase, also suppression proliferation of mesangial cells, mitigation
The effect of renal hypertrophy.Add suitable adjuvant in astragaloside, can be made into oral formulations, it is used for preventing and treating diabetes
Nephropathy.This product has enhancing immunity, strengthens energy, resisting fatigue, mutation, liver protection, the effect of suppression osteoclast.In tradition
Medical science thinks, the Radix Astragali has functions that tonifying Qi and lifting yang, strengthening superficial resistance to stop perspiration, expelling pus and toxin by strengthening QI, inducing diuresis to remove edema, expelling pus and promoting granulation.Modern pharmacology
Research shows, the Radix Astragali has an enhancing human body immunity function, heart tonifying blood pressure lowering, blood sugar lowering, diuresis, defying age, resisting fatigue, antitumor,
Antiviral, calmness, analgesia etc. act on.Astragalus polysaccharidess 250mg/kg, 500mg/kg lumbar injection, to normal mouse and hydrogenation can
" yang deficiency " mice caused by pine, room temperature swimming time all has notable prolongation effect, and increases mice adrenal gland weight under stress state.
Radix Astragali extractive solution is to class in the rat plasma Determination of cortisol under Suppressor cells state, adrenal gland's weight and adrenal cortical cell
Lipid void content is all significantly improved effect.Cerebral anoxia caused by the ligation of carotid of both sides, all has notable antagonism, can be bright
The aobvious time-to-live extending mice.To prevention senile arteriosclerosis, improve old and feeble pulmonary function has certain meaning to the Radix Astragali.Body
Outer culture human embryonic lung diploid fibroblast survived to 52 generations, and contained 0.2% Radix Astragali and produce the cultured cells of liquid and survive to 77
In generation, in medication group cellular senescence process, the change of organelle is essentially identical with the old and feeble no-load voltage ratio rule of cellular control unit, but it changes
Become mild degree, rate of change is relatively slow, and the Golgi complex of particularly medication group cell is especially flourishing, although cell declines
Their not very agings always.Research has shown that the Radix Astragali has the good effect lengthened the life, and using it as the anti-ageing medicine lengthening one's life, is worth height
Degree is paid attention to and is developed.Astragalus polysaccharidess have obvious antagonism to tubercle bacillus affection;And have been found that other compositions such as aminoacid, biology
Alkali, flavone etc. have the effect of the raw stomatitis virus of significantly anti-folliculus.Animal and development of evil in febrile disease cell experiment show, Radix Astragali injection pair
In mice neonatal rat body, epidemic hemorrhagic fever, the course of infection of virus (EHFV) have certain blocking effect.The Radix Astragali is congratulated to external will
Shigella flexneri, anthrax bacillus, a- promoting blood circulation streptococcus, Streptococcus sanguiss, diphtheria corynebacterium, bacillus pseudodiphthericus, Diplococcus pneumoniae, golden yellow
Color staphylococcuses, Staphylococcus citreus, Staphylococcus albus and bacillus subtilis etc. have antibacterial action.
Radix Puerariae extract derives from the dry root of legume pueraria lobata.Perennial fallen leaves liana, up to 10m, Herb is yellow
Brown coarse wool.Tuber is cylindric, plump, crust lark, internal silty, and fibroids are very strong.It is born in hillside thick grass roadside and dredge
More dark and damp place in woods.Energy expansion of blood vessels, improves blood circulation;Reduce myocardial oxygen consumption, anticancer;Increase arteria coronaria stream
Amount, adjusts blood microcirculation;Treat the sudden deafness of each age level;Reduce cardiovascular and cerebrovascular disease dangerous.Have blood sugar lowering,
Blood fat, antiinflammatory etc. act on.
Concha Ostreae extract, another name oyster clam, left Gu Concha Ostreae, are a kind of brownish-yellow powder.Purposes:Medicines and Health Product, beverage and
Food additive etc..Meridian distribution of property and flavor:It is slightly cold;Salty;Return liver, gallbladder, kidney channel.Indication:Suppressing the hyperactive liver and subsiding YANG, hard masses softening and resolving, convergence is solid
Puckery.For insomnia of palpitating with fear, vertigo and tinnitus, scrofula subcutaneous nodule, abdominal mass mass in the abdomen.
Magnesium stearate is the fine powder of the light no grittiness of white;Micro- have special smell;Contact soapy feeling with skin.This product water,
Insoluble in ethanol or ether, it is mainly used as lubricant, antiplastering aid, fluidizer.Particularly suitable oils, the granulation of extract medicament,
The granule made has good mobility and compressibility.It is used as fluidizer in direct compression.It is alternatively arranged as filter aid, clarification
Agent and drip infusion, and the suspending agent of liquid preparation, thickening agent.Purposes is stabilizer;Lubricant;Pharmaceutic adjuvant.
Specific embodiment
Increase the capsule of bone density, implant is prepared from by the raw material of following weight:25 grams of Rhizoma Drynariae extract, Du
25 grams of secondary extract, 80 grams of Radix Astragali extract, 70 grams of Radix Puerariae extract, 180 grams of Concha Ostreae extract, 18 grams of starch, magnesium stearate 2
Gram.Above-mentioned raw materials make 1000 capsules, 0.4 gram every.Starch and magnesium stearate meet Pharmacopoeia of People's Republic of China 2005
The relevant regulations of year version two, major ingredient meets the requirement of company standard Appendix B, and described capsule body is No. 0 Capsuleses, symbol
Close the regulation of Pharmacopoeia of People's Republic of China version Capsuleses in 2000.
A kind of preparation method of the capsule increasing bone density as above, its preparation method is as follows:
1)The raw material of above-mentioned weight is crossed respectively standby after 60 mesh sieves;
2)The raw material of the above-mentioned weight after sieving is placed in mixer and mixes 30 minutes, is allowed to uniform color unanimously, obtains mixing
Powder;
3)Using capsule filling machine, above-mentioned mixed powder is filled in capsule body, 0.4 gram every, the capsule body filled is placed in
Polish in capsule polisher, make capsule surface bright and clean, screened after polishing, choose flat capsule, broken capsule, empty pocket and leakage powder capsule;
4)Pass through Aluminium-coating Packer with the PVC board meeting YBB00212005 standard and the aluminium foil meeting YBB00152002 standard
To step 3)Capsule after middle screening is wrapped inside dress, the every plate of packing specification 12;
5)Outer package operation mounted box, every box 2 plate will be proceeded to through the packaged capsule of Aluminium-coating Packer, obtain finished product, packing instructions:
After receiving etui, by printed for box lot number, print procedure requires the name of an article, specification, and lot number printing is clear, correct, and finished product is used
Co60Sterilizing, dosage is 6KGy, extracts inspection, put in storage after the assay was approved after sterilizing.
Claims (3)
1. a kind of capsule increasing bone density, makes including capsule body and the implant being filled in capsule body, its feature exists
In described implant is to be prepared from by the raw material of following parts by weight:25 parts of Rhizoma Drynariae extract, Cortex Eucommiae extract 25
Part, 80 parts of Radix Astragali extract, 70 parts of Radix Puerariae extract, 180 parts of Concha Ostreae extract, 18 parts of starch, 2 parts of magnesium stearate.
2. according to claim 1 increase bone density capsule it is characterised in that:Described capsule body is No. 0 hollow glue
Capsule.
3. a kind of as claimed in claim 1 increase bone density capsule preparation method it is characterised in that its preparation method such as
Under:
1)The raw material of above-mentioned parts by weight is crossed respectively standby after 60 mesh sieves;
2)The raw material of the above-mentioned parts by weight after sieving is placed in mixer and mixes 30 minutes, obtains mixed powder;
3)Using capsule filling machine, above-mentioned mixed powder is filled in capsule body, the capsule body filled is placed in capsule polisher
Middle polishing, is screened after polishing, chooses flat capsule, broken capsule, empty pocket and leakage powder capsule;
4)Pass through Aluminium-coating Packer with the PVC board meeting YBB00212005 standard and the aluminium foil meeting YBB00152002 standard
To step 3)Capsule after middle screening is wrapped inside dress, the every plate of packing specification 12;
5)Outer package operation mounted box, every box 2 plate will be proceeded to through the packaged capsule of Aluminium-coating Packer, obtain finished product, finished product Co60
Sterilizing, dosage is 6KGy, extracts inspection, put in storage after the assay was approved after sterilizing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611079024.6A CN106420905A (en) | 2016-11-30 | 2016-11-30 | Capsule for increasing bone density and preparation method of capsules |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611079024.6A CN106420905A (en) | 2016-11-30 | 2016-11-30 | Capsule for increasing bone density and preparation method of capsules |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106420905A true CN106420905A (en) | 2017-02-22 |
Family
ID=58223005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611079024.6A Pending CN106420905A (en) | 2016-11-30 | 2016-11-30 | Capsule for increasing bone density and preparation method of capsules |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106420905A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108310206A (en) * | 2018-03-05 | 2018-07-24 | 哈尔滨医科大学 | A kind of Chinese medicine composition and its preparation method and application for preventing or treating osteoporosis |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101292739A (en) * | 2008-05-21 | 2008-10-29 | 南方李锦记有限公司 | Health food having function of increasing compact bone substance density |
CN104224883A (en) * | 2014-08-21 | 2014-12-24 | 杭州双马生物工程有限公司 | Capsule for enhancing bone mineral density and preparation method thereof |
-
2016
- 2016-11-30 CN CN201611079024.6A patent/CN106420905A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101292739A (en) * | 2008-05-21 | 2008-10-29 | 南方李锦记有限公司 | Health food having function of increasing compact bone substance density |
CN104224883A (en) * | 2014-08-21 | 2014-12-24 | 杭州双马生物工程有限公司 | Capsule for enhancing bone mineral density and preparation method thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108310206A (en) * | 2018-03-05 | 2018-07-24 | 哈尔滨医科大学 | A kind of Chinese medicine composition and its preparation method and application for preventing or treating osteoporosis |
CN108310206B (en) * | 2018-03-05 | 2021-11-23 | 哈尔滨医科大学 | Traditional Chinese medicine composition for preventing or treating osteoporosis and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102091234B (en) | Traditional Chinese medicine composition for treating bone fracture diseases | |
CN110447902B (en) | Composition with weight-losing effect | |
CN104127698A (en) | Traditional Chinese medicinal composition for nerve calming and melancholy dispelling, and preparation method and application thereof | |
CN106136048A (en) | Person in middle and old age's health porridge powder and preparation method thereof | |
CN104474385A (en) | Medicine for treating incoordination between spleen and stomach and preparation method of medicine | |
CN104225361A (en) | Health wine with radix salviae miltiorrhizae and pseudo-ginseng and preparation method of health wine | |
CN104225417A (en) | Traditional Chinese medicine composition with function of assisting improvement of memory and preparation method thereof | |
CN103990079A (en) | Pharmaceutical composition for treating Qi-stagnation and blood stasis type lumbar muscle strain and preparation method of pharmaceutical composition | |
CN106173450A (en) | Improve compound feed additive and the feedstuff of pigeon immunity | |
CN105708970A (en) | Health food with blood sugar reducing function | |
CN106177477A (en) | A kind of health composition for blood sugar lowering, blood fat reducing and blood pressure lowering | |
CN102552779A (en) | Health-care traditional Chinese medicine composition with effect of human body blood purification and health-care product thereof | |
CN103520302B (en) | Sea-buckthorn leaf anti-fatigue capsule and preparation method thereof | |
CN106420905A (en) | Capsule for increasing bone density and preparation method of capsules | |
CN104605372A (en) | Nutritional herbal cuisine based on cancer radiotherapy patient and preparation method thereof | |
CN102302579B (en) | Medicament for treating obesity | |
CN103768570B (en) | A kind of Chinese medicine composition for the treatment of acute cholecystitis and preparation method thereof | |
CN104740415A (en) | Traditional Chinese medicine preparation for treating osteoporosis of lactation-period female | |
CN102488769B (en) | Diet pill | |
CN104857421A (en) | Porridge product for treating deficiency of spleen and stomach and preparation method of porridge product | |
CN105012746A (en) | Pain-relieving capsule for treating migraine and preparation method of pain-relieving capsule | |
CN105194433A (en) | Traditional Chinese medicine composition for medically treating body deficiency syndromes of the aged | |
CN105560551A (en) | Traditional Chinese medicine composition for treating hyperlipidemia diseases and preparation method thereof | |
KR100882784B1 (en) | Functional food composition having anti-arthritic activity | |
CN106177480A (en) | A kind of Hyperglycemic health care compositions comprising leaf of Cyclocarya paliurus Iljinskaja and Herba Dendrobii |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170222 |